Cover Image

Autoimmune colitis and neutropenia in adjuvant anti-PD-1 therapy for malignant melanoma: efficacy of Vedolizumab, a case report

Immune checkpoint inhibitors (ICIs) represent an important advance in the adjuvant treatment of patients with high-risk melanoma. Although the safety profile of anti-programmed cell death protein-1 (PD-1) is fairly acceptable, different immune-related adverse events (irAEs) are described. Herein we...

Full description

Saved in:
Bibliographic Details
Main Authors: Maria d'Apolito (Author), Rocco Spagnuolo (Author), Maria Anna Siciliano (Author), Vito Barbieri (Author), Cristina Cosco (Author), Lucia Fiorillo (Author), Onofrio Cuomo (Author), Valeria Zuccalà (Author), Pierpaolo Correale (Author), Licia Pensabene (Author), Marco Rossi (Author), Patrizia Doldo (Author), Pierfrancesco Tassone (Author), Pierosandro Tagliaferri (Author)
Format: Book
Published: SAGE Publishing, 2022-01-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items